| 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial … B Ibanez, S James, S Agewall, MJ Antunes, C Bucciarelli-Ducci, H Bueno, ... European heart journal 39 (2), 119-177, 2018 | 11739 | 2018 |
| Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia AS Marsin, L Bertrand, MH Rider, J Deprez, C Beauloye, MF Vincent, ... Current biology 10 (20), 1247-1255, 2000 | 1027 | 2000 |
| Insulin signalling in the heart L Bertrand, S Horman, C Beauloye, JL Vanoverschelde Cardiovascular research 79 (2), 238-248, 2008 | 362 | 2008 |
| AMPK: Lessons from transgenic and knockout animals B Viollet, Y Athea, R Mounier, B Guigas, E Zarrinpashneh, S Horman, ... Frontiers in bioscience (Landmark edition) 14, 19, 2009 | 357 | 2009 |
| SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule A Werion, L Belkhir, M Perrot, G Schmit, S Aydin, Z Chen, A Penaloza, ... Kidney international 98 (5), 1296-1307, 2020 | 274 | 2020 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 258 | 2019 |
| Sustained activation of AMP‐activated protein kinase induces c‐Jun N‐terminal kinase activation and apoptosis in liver cells D Meisse, M Van de Casteele, C Beauloye, I Hainault, BA Kefas, ... FEBS letters 526 (1-3), 38-42, 2002 | 235 | 2002 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 231 | 2021 |
| AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure C Beauloye, L Bertrand, S Horman, L Hue Cardiovascular research 90 (2), 224-233, 2011 | 216 | 2011 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 194 | 2019 |
| AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation R Gélinas, F Mailleux, J Dontaine, L Bultot, B Demeulder, A Ginion, ... Nature communications 9 (1), 374, 2018 | 194 | 2018 |
| AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B L Bertrand, A Ginion, C Beauloye, AD Hebert, B Guigas, L Hue, ... American Journal of Physiology-Heart and Circulatory Physiology 291 (1 …, 2006 | 177 | 2006 |
| Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase C Belge, J Hammond, E Dubois-Deruy, B Manoury, J Hamelet, ... Circulation 129 (4), 451-462, 2014 | 169 | 2014 |
| Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides C Beauloye, AS Marsin, L Bertrand, U Krause, DG Hardie, ... FEBS letters 505 (3), 348-352, 2001 | 162 | 2001 |
| Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2 S Horman, C Beauloye, D Vertommen, JL Vanoverschelde, L Hue, ... Journal of Biological Chemistry 278 (43), 41970-41976, 2003 | 151 | 2003 |
| AMP-activated Protein Kinase Phosphorylates and Desensitizes Smooth Muscle Myosin Light Chain Kinase*♦ S Horman, N Morel, D Vertommen, N Hussain, D Neumann, C Beauloye, ... Journal of Biological Chemistry 283 (27), 18505-18512, 2008 | 143 | 2008 |
| Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways L Hue, C Beauloye, AS Marsin, L Bertrand, S Horman, MH Rider Journal of molecular and cellular cardiology 34 (9), 1091-1097, 2002 | 135 | 2002 |
| NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1 M Balteau, N Tajeddine, C De Meester, A Ginion, C Des Rosiers, ... Cardiovascular research 92 (2), 237-246, 2011 | 131 | 2011 |
| AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation EP Daskalopoulos, C Dufeys, L Bertrand, C Beauloye, S Horman Journal of Molecular and Cellular Cardiology 91, 188-200, 2016 | 123 | 2016 |
| AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes M Balteau, A Van Steenbergen, AD Timmermans, C Dessy, ... American Journal of Physiology-Heart and Circulatory Physiology 307 (8 …, 2014 | 115 | 2014 |
Jean-Louis VanoverscheldeUniversité catholique de Louvain在 uclouvain.be 的电子邮件经过验证
